prégabaline 25

Phase III trial Pregabalin in the prevention & reduction of PreOx

la description:
ASCO 2015: Daniel Ciampi de Andrade discusses a phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx).\n\nFor more oncology news, education, and information, please visit http://www.oncology.tv/

You may also like...

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *